acetylcysteine has been researched along with ristocetin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Fu, X; Gushiken, FC; López, JA; Moake, JL; Ni, H; Nolasco, L; Reheman, A | 1 |
Ali, C; Denis, CV; Diamond, SL; Gakuba, C; Gauberti, M; Herbig, BA; Lenting, PJ; Martinez de Lizarrondo, S; Repessé, Y; Touzé, E; Vivien, D | 1 |
2 other study(ies) available for acetylcysteine and ristocetin
Article | Year |
---|---|
N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice.
Topics: Acetylcysteine; ADAMTS13 Protein; Animals; Anti-Bacterial Agents; Endothelial Cells; Humans; Male; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Mice, Knockout; Plasma; Platelet Aggregation; Protein Multimerization; Purpura, Thrombotic Thrombocytopenic; Ristocetin; Thrombosis; von Willebrand Factor | 2011 |
Potent Thrombolytic Effect of
Topics: Acetylcysteine; Animals; Blood Platelets; Chlorides; Disease Models, Animal; Ferric Compounds; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Male; Mice; Platelet Aggregation; Ristocetin; Thromboembolism; Thrombosis; Tissue Plasminogen Activator; von Willebrand Factor | 2017 |